{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:51:57Z","timestamp":1792547517402,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Sk\u00e5ne University Hospital Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Phaeochromocytoma is sometimes not diagnosed before surgery and may present as an adrenal incidentaloma. The aim of this study was to investigate differences in clinical presentation and perioperative outcome in patients with subclinical and symptomatic phaeochromocytoma, and in patients operated with and without preoperative \u03b1-blockade.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a retrospective observational study of patients with a histopathological diagnosis of phaeochromocytoma registered in Eurocrine\u00ae, the European registry for endocrine tumours, between 1 January 2015 and 31 March 2020. Patient characteristics, clinical presentation, tumour detection, and perioperative variables were analysed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Some 551 patients were included. Of these, 486 patients (88.2 per cent) had a preoperative diagnosis of phaeochromocytoma. Tumours were detected as incidentalomas in 239 patients (43.4 per cent) and 265 (48.1 per cent) had a preoperative diagnosis of hypertension. Preoperative \u03b1-blockade was more frequently used in patients with a known phaeochromocytoma (350, 90.9 per cent) than in patients with other indications for adrenalectomy (16, 31 per cent). Complications did not differ between patients who had surgery because of catecholamine excess compared with those who had other indications for surgery (19 (3.9 per cent) versus 2 (3 per cent); P\u2009=\u20090.785), nor did the conversion rate from minimally invasive to open surgery differ between the groups. There were no obvious differences in complications, according to the Clavien\u2013Dindo classification, based on preoperative \u03b1-blockade or not.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Subclinical phaeochromocytoma detected incidentally is common. A significant proportion of patients with phaeochromocytoma did not have \u03b1-blockade before surgery, without an apparent effect on complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjs\/znab199","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T12:24:58Z","timestamp":1620649498000},"page":"1199-1206","source":"Crossref","is-referenced-by-count":21,"title":["Adrenalectomy for incidental and symptomatic phaeochromocytoma: retrospective multicentre study based on the Eurocrine\u00ae database"],"prefix":"10.1093","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7019-8532","authenticated-orcid":false,"given":"L","family":"Hallin Thompson","sequence":"first","affiliation":[{"name":"Department of Surgery, Sk\u00e5ne University Hospital , Lund, Sweden"},{"name":"Department of Clinical Sciences, Lund University , Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6","family":"Makay","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Division of Endocrine Surgery, Ege University Hospital , Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-6660","authenticated-orcid":false,"given":"L","family":"Brunaud","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal, Metabolic and Surgical Oncology, Universit\u00e9 de Lorraine, CHU Nancy, Hospital Brabois Adultes , Vandoevre les Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1259-2491","authenticated-orcid":false,"given":"M","family":"Raffaelli","sequence":"additional","affiliation":[{"name":"Division of Endocrine and Metabolic Surgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS , Rome, Italy"},{"name":"Dipatimento Universitario di Medicina e Chirurgia Traslazionale, Universit\u00e0 Cattolica del Sacro Cuore , Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-6025","authenticated-orcid":false,"given":"A","family":"Bergenfelz","sequence":"additional","affiliation":[{"name":"Department of Surgery, Sk\u00e5ne University Hospital , Lund, Sweden"},{"name":"Department of Clinical Sciences, Lund University , Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Eurocrine Council","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Musholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Almquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Barczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6","family":"Makay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Munos P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Brunaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Van Slycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Riss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Iacobone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Nordenstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"2023063010261931500_znab199-B1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/er.2002-0013","article-title":"Pheochromocytoma: state-of-the-art and future prospects","volume":"24","author":"Bravo","year":"2003","journal-title":"Endocr Rev"},{"key":"2023063010261931500_znab199-B2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.beem.2011.10.008","article-title":"Subclinical phaeochromocytoma","volume":"26","author":"Mannelli","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2023063010261931500_znab199-B3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/EJE-09-0384","article-title":"Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma","volume":"161","author":"Kopetschke","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2023063010261931500_znab199-B4","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1210\/jc.2013-1844","article-title":"Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics","volume":"98","author":"Haissaguerre","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2023063010261931500_znab199-B5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.mpaic.2008.07.020","article-title":"Recognition and management of phaeochromocytoma","volume":"9","author":"Lewis","year":"2008","journal-title":"Anaesth Intensive Care Med"},{"key":"2023063010261931500_znab199-B6","first-page":"1915","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","author":"Lenders","year":"2014"},{"key":"2023063010261931500_znab199-B7","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1002\/bjs.11348","article-title":"Meta-analysis of \u03b1-blockade versus no blockade before adrenalectomy for phaeochromocytoma","volume":"107","author":"Schimmack","year":"2020","journal-title":"Br J Surg"},{"key":"2023063010261931500_znab199-B8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/bja\/aew392","article-title":"Perioperative \u03b1-receptor blockade in phaeochromocytoma surgery: an observational case series","volume":"118","author":"Groeben","year":"2017","journal-title":"Br JAnaesth"},{"key":"2023063010261931500_znab199-B9","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.surg.2014.08.022","article-title":"Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma","volume":"156","author":"Brunaud","year":"2014","journal-title":"Surgery"},{"key":"2023063010261931500_znab199-B10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12020-009-9260-5","article-title":"Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience","volume":"37","author":"Comlekci","year":"2010","journal-title":"Endocrine"},{"key":"2023063010261931500_znab199-B11","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2023063010261931500_znab199-B12","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2023063010261931500_znab199-B13"},{"key":"2023063010261931500_znab199-B14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"2023063010261931500_znab199-B15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00423-016-1535-8","article-title":"Risk factors for complications after adrenalectomy: results from a comprehensive national database","volume":"402","author":"Thompson","year":"2017","journal-title":"Langenbecks Arch Surg"},{"key":"2023063010261931500_znab199-B16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.surg.2019.03.034","article-title":"Patient selection and outcomes of laparoscopic transabdominal versus posterior retroperitoneal adrenalectomy among surgeons in the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP)","volume":"167","author":"Marrero","year":"2020","journal-title":"Surgery"},{"key":"2023063010261931500_znab199-B17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamasurg.2018.2648","article-title":"Risk factors associated with perioperative complications and prolonged length of stay after laparoscopic adrenalectomy","volume":"153","author":"Chen","year":"2018","journal-title":"JAMA Surg"},{"key":"2023063010261931500_znab199-B18","first-page":"1","article-title":"Retrospective comparison of three minimally invasive approaches for adrenal tumors: perioperative outcomes of transperitoneal laparoscopic, retroperitoneal laparoscopic and robot-assisted laparoscopic adrenalectomy","volume":"20","author":"Changwei","year":"2020","journal-title":"BMC Urology"},{"key":"2023063010261931500_znab199-B19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-19-0159","article-title":"Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion","volume":"181","author":"Geroula","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"2023063010261931500_znab199-B20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0004563217739931","article-title":"Clinical evaluation and treatment of phaeochromocytoma","volume":"55","author":"Davison","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"2023063010261931500_znab199-B21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023063010261931500_znab199-B22","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1210\/jc.2012-1061","article-title":"Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?","volume":"97","author":"Sane","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2023063010261931500_znab199-B23","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/0895-7061(96)00057-X","article-title":"Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma","volume":"9","author":"Streeten","year":"1996","journal-title":"Am J Hypertens"},{"key":"2023063010261931500_znab199-B24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1373\/clinchem.2004.045484","article-title":"Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines","volume":"51","author":"Eisenhofer","year":"2005","journal-title":"Clin Chem"},{"key":"2023063010261931500_znab199-B25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2016.01.022","article-title":"Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era","volume":"100","author":"Pillai","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"2023063010261931500_znab199-B26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"2023063010261931500_znab199-B27","first-page":"1","article-title":"Update of pheochromocytoma syndromes: genetics, biochemical evaluation, and imaging","volume":"9","author":"Rami","year":"2018","journal-title":"Front Endocrinol"},{"key":"2023063010261931500_znab199-B28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2023063010261931500_znab199-B29","doi-asserted-by":"crossref","first-page":"E3374","DOI":"10.1210\/clinem\/dgaa423","article-title":"Glucocorticoid excess in patients with pheochromocytoma compared with paraganglioma and other forms of hypertension","volume":"105","author":"Constantinescu","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/108\/10\/1199\/50744466\/znab199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/108\/10\/1199\/50744466\/znab199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T10:27:05Z","timestamp":1688120825000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/108\/10\/1199\/6321579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,7,16]]},"published-print":{"date-parts":[[2021,10,23]]}},"URL":"https:\/\/doi.org\/10.1093\/bjs\/znab199","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,7,16]]}}}